These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32795354)

  • 21. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
    Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
    J Neural Transm (Vienna); 2015 Jan; 122(1):59-68. PubMed ID: 25448875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R
    J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.
    Li WX; Lv WW; Dai SX; Pan ML; Huang JF
    Lipids Health Dis; 2015 Sep; 14():101. PubMed ID: 26337056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
    Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
    Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.
    Zhang N; Ji L; Chen Z; An L; Ren D; Bi Y; Guo Z; Yuan R; Yuan F; Dong Z; Yin L; Sun X; Yang F; Li X; Yu T; He L; Shi L; He G
    Psychiatr Genet; 2020 Feb; 30(1):30-33. PubMed ID: 31842058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.
    Xu Z; Zhang Z; Shi Y; Pu M; Yuan Y; Zhang X; Li L; Reynolds GP
    J Psychopharmacol; 2012 Mar; 26(3):349-59. PubMed ID: 21937687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on Environmental Causes and SNPs of MTHFR, MS and CBS Genes Related to Congenital Heart Disease.
    Shi H; Yang S; Liu Y; Huang P; Lin N; Sun X; Yu R; Zhang Y; Qin Y; Wang L
    PLoS One; 2015; 10(6):e0128646. PubMed ID: 26035828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinase gene haplotypes and gene-gene interactions in the Ras-Raf-MAPK signaling pathway: association with antidepressant remission.
    Wang CJ; Zhang ZJ; Xu Z; Shi YY; Pu MJ; Zheng Z; Wang XZ; Zhang YM; Li LJ
    Int Clin Psychopharmacol; 2013 Sep; 28(5):245-54. PubMed ID: 23727904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
    O'Connell CP; Goldstein-Piekarski AN; Nemeroff CB; Schatzberg AF; Debattista C; Carrillo-Roa T; Binder EB; Dunlop BW; Craighead WE; Mayberg HS; Williams LM
    Am J Psychiatry; 2018 Mar; 175(3):251-261. PubMed ID: 29241359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.
    Xu Z; Chen Z; Shen T; Chen L; Tan T; Gao C; Chen B; Yuan Y; Zhang Z
    Psychiatry Clin Neurosci; 2022 Feb; 76(2):51-57. PubMed ID: 34773671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke.
    Kim OJ; Hong SP; Ahn JY; Hong SH; Hwang TS; Kim SO; Yoo W; Oh D; Kim NK
    Yonsei Med J; 2007 Apr; 48(2):201-9. PubMed ID: 17461517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees.
    Bousman CA; Potiriadis M; Everall IP; Gunn JM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):68-76. PubMed ID: 24123968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine levels, MTHFR C677T genotype, and MRI Hyperintensities in late-onset major depressive disorder.
    Chen CS; Tsai JC; Tsang HY; Kuo YT; Lin HF; Chiang IC; Devanand DP
    Am J Geriatr Psychiatry; 2005 Oct; 13(10):869-75. PubMed ID: 16223965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
    Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
    Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of mutated methylenetetrahydrofolate reductase 677C-->T and 1298A-->C genetics single nucleotide polymorphisms (SNPs) in Sub-Saharan populations.
    Adjalla CE; Amouzou EK; Sanni A; Abdelmouttaleb I; Chabi NW; Namour F; Soussou B; Guéant JL
    Clin Chem Lab Med; 2003 Aug; 41(8):1028-32. PubMed ID: 12964809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of homocysteine for depression after acute coronary syndrome.
    Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Kang H; Moon WJ; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    Oncotarget; 2016 Oct; 7(42):69032-69040. PubMed ID: 27626182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.